Condyle
发表于 2025-3-30 09:15:31
http://reply.papertrans.cn/23/2218/221791/221791_51.png
温室
发表于 2025-3-30 13:52:12
http://reply.papertrans.cn/23/2218/221791/221791_52.png
Contort
发表于 2025-3-30 18:31:16
http://reply.papertrans.cn/23/2218/221791/221791_53.png
Cerumen
发表于 2025-3-30 22:56:57
Evolution of Cardiac Markers in Clinical Trialspast, however, the value of biochemical markers was limited by their rather simplistic ability to categorize patients into one of two groups—those with myocardial infarctions (MI) and those without. Their initial place in clinical trials was therefore often confined to defining specific patient popu
Negligible
发表于 2025-3-31 03:37:34
Assessing Reperfusion and Prognostic Infarct Sizing with Biochemical Markersocused on treatments aimed at limiting infarct size by improving myocardial oxygen supply, lowering myocardial oxygen demand, and minimizing autolytic damage to myocytes .,.. The thrombus became the primary therapeutic target for reperfusion therapy and monitoring because it is a keystone pathophysi
Antimicrobial
发表于 2025-3-31 07:58:53
http://reply.papertrans.cn/23/2218/221791/221791_56.png